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ABSTRACT OF THE DISSERTATION

Biochemical Characteristics of Inconsistent Free T4 Assays
by
Kristofer S. Fritz
Doctor of Philosophy, School of Medicine, Program in Biochemistry
Loma Linda University, May 2007
Dr. Bruce Wilcox, Chairperson

Serum levels of free thyroxine (T4) are helpful in the clinical evaluation of
patients who are suspected of having thyroid disease, since free T4 (unbound) is known to
closely relate to hyper, eu and hypothyroidism. There are documented inconsistencies
among commercially available direct free thyroxine immunoassays. The biochemical
basis for these inconsistencies is not understood and has not been characterized. Direct
free T4 measurements have been linked to both T4-binding serum protein concentrations
and protein-bound T4 concentrations. A free T4 reference method using direct equilibrium
dialysis radioimmunoassay has been well characterized. New experiments have applied
this equilibrium dialysis reference method and a well characterized total T4 immunoassay
to the characterization of eight commercially available direct free T4 immunoassays. The
data contained in this dissertation show that these direct free T4 determinations correlate
with protein-bound T4 concentrations, total T4 concentrations or both. These direct free T4
immunoassays are non-specific, insensitive and inaccurate when used to measure normal
levels of free thyroxine in serum.
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CHAPTER 1
INTRODUCTION

Approximately 27 million Americans are affected by thyroid disease (ie.
hyperthyroidism, hypothyroidism...). The thyroid is the largest endocrine gland in the
human body and is located just below the Adam’s apple at the base of the neck
(Braverman 1996). It produces and secretes the thyroid hormones triiodothyronine (T3)
and thyroxine (T4) (Figure 1.1) and is closely regulated by the hypothalamic-pituitarythyroid axis (Figure 1.2). Thyroid hormones regulate the rate of metabolism and affect
the function of many systems in the body. In humans, T3 and T4 are bound to and
transported by three serum proteins; approximately 75%, 15% and 10% of T4 is bound to
thyroxine binding globulin (TBG), transthyretin (TTR) and albumin, respectively. Only a
small fraction of T3 (0.5%) and T4 (0.02%) remain unbound or free in circulation. It is this
free fraction of thyroid hormone that is metabolically active, exerting the hormone’s
action on cellular processes and correlating with clinical presentation and symptoms.
Over the past five decades the clinical relevance of free T4 has led to the
development of many different free T4 immunoassays. These assays are classified into
one of two distinct categories (Holm 2004). Methods calibrated using gravimetrically
prepared mass standards dissolved in buffer solutions are absolute methods. Methods
calibrated using serum standards containing free hormone concentrations that are
determined using an absolute method are comparative methods (Ekins 1993).
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Figure 1.1 Thyroid hormones.
Triiodothyronine (T3) and Tetraiodothyronine (thyroxine, T4) are secreted by the
thyroid.
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Figure 1.2 Hypothalamic-pituitary-thyroid axis.
Thyroid hormone levels are regulated by a feedback inhibition mechanism which
operates along the hypothalamic-pituitary-thyroid axis. The hypothalamus
secretes TRH which stimulates the pituitary to secrete TSH. TSH, in turn,
stimulates the thyroid gland to produce and secrete thyroid hormones (T3 and T4)
into circulation. Once levels of T3 and T4are adequate, further production of TSH
is suppressed according to the familiar negative feedback mechanism. There is,
therefore, an inverse relationship between TSH and thyroid hormone levels.
Because physiological activity is exerted by the free hormones (those not bound
to binding proteins), this inverse relationship is actually between TSH and the
free thyroid hormones. (Illustration taken from www.dpcweb.com)
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Absolute and comparative methods can be further classified as being indirect or direct
assays. Indirect methods combine the measurements of total hormone concentrations and
the free hormone fraction. Direct methods result in an estimate of free hormone
concentration from a single measurement without determining the total hormone
concentration. Today, most commercially available free T4 immunoassays are direct
comparative methods. Unfortunately, great inconsistencies exist among these assays.
When the same serum is analyzed by various assays, reported T4 determinations are often
in disagreement (Helenius 1983, Hay 2002).
Current reference methods for the determination of free T4 levels in serum
incorporate equilibrium dialysis or ultrafiltration to separate free T4 from serum proteins
and are coupled with direct radioimmunoassays or direct mass spectrometry methods for
the quantification of T4 concentrations (Figure 1.3) (Soldin 2005, Van Uytfanghe 2006).
These methods must minimize technical uncertainties such as adsorption, dilution,
protein leakage and the alteration of protein-hormone binding equilibria. Equilibrium
dialysis involves the dilution of serum small molecules, while ultrafiltration has a
concentrating effect on serum proteins and protein bound molecules. When using either
method, the effects of dilution and concentration must be well characterized. Also, the
leakage of serum proteins into dialysates and ultrafiltrates is known to produce spurious
free T4 determinations. Both methods must be verified as retaining all T4 binding serum
proteins, thus eliminating the possibility of protein interference. Some or all of the
aforementioned variables exist for every free T4 assay, and must be dealt with in a
systematic manner (Korsgaard 1961, Olsen 1979, Ekins 1990, Holm 2002).

6

Figure 1.3 Ultrafiltration and equilibrium dialysis.
Ultrafiltration and equilibrium dialysis are commonly used to obtain the free or unbound
fraction of T4 from serum samples. Serum proteins and protein bound T4 are retained by
these devices while free T4 is collected. (THBP — Thyroid Hormone Binding Protein)
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All clinical laboratory free T4 assays are competitive binding immunoassays. Two
groups of free T4 immunoassays are currently used. In one group, free T4 values are based
on the binding and displacement of radiolabeled T4 from T4 antibody. As previously
described, these assays use equilibrium dialysis or ultrafiltration to separate free T4 from
T4 binding proteins and from protein bound T4 prior to quantification of free T4 by
immunoassay (Figure 1.3). In the second group, free T4 measurements are based on the
binding and displacement of large molecular conjugates of T4, called “analogs” of T4
(Figure 1.4). Analogs selected for use in these free T4 immunoassays should not bind to
endogenous T4 binding serum proteins. These assays were developed to avoid the need
for “technically demanding” and time consuming equilibrium dialysis or ultrafiltration
procedures. These analog-based direct free T4 assays are applied directly to serum or
plasma.
The vast majority of free T4 assays used today are applied directly to human sera
and are analog-based methods. The analytical chemistry of these methods is highly
inconsistent. Their sensitivity is variable, and their specificity is uncertain (Stockigt 1981,
Amino 1983, Csako 1987, Nelson 1994, Christofides 1999, Wang 2000, Nelson 2004).
Nearly all are incompletely characterized.
The free T4 immunoassays used in conjunction with equilibrium dialysis and
ultrafiltration are non-analog methods (Figure 1.4). They detect and quantify serum free
T4 after it has been separated from proteins and protein bound T4. Because of this
separation, they are thought to be unaffected by serum proteins and protein bound T4.
They are more sensitive for detecting free T4 than analog-based methods, by two or more
log orders of magnitude.

9

Figure 1.4 Illustration of a non-analog free T4 immunoassay and an analog-based
free T4 immunoassay.
The non-analog assay is applied to serum dialysate or ultrafiltrate, containing free T4 in
the absence of serum proteins. The analog-based assay is applied to whole serum.
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There are both numerical inconsistencies and categorical (high, normal or low)
inconsistencies among analog-based free T4 determinations. There are also quantitative
and categorical inconsistencies between analog and non-analog methods. Most of these
reports are observational studies that document the presence of inconsistencies (Stockigt
1981, Amino 1983, Csako 1987, Nelson 1994, Christofides 1999, Wang 2000, Nelson
2004). Few studies have reported controlled experiments using fixed or excluded
variables. The clinical experience of senior endocrinologists has led to the conclusion that
analog-based free T4 immunoassays are variably inaccurate and unreliable. The
biochemical conditions that account for all of this have not been reported.
Various hypothetical explanations exist regarding these inconsistencies. The most
widely accepted explanation is that these different analog-based free T4 methods are
calibrated to different free T4 standards. Efforts to standardize all direct free T4
immunoassay calibrations are just underway by a working group of the International
Federation of Clinical Chemistry, led by scientists at the University of Ghent in Belgium.
A more likely explanation is that serum proteins and protein bound T4 influence analogbased free T4 determinations, and their influence varies from method to method. Our goal
was to perform a systematic study of these effects to answer the question; what are the
biochemical conditions under which direct free T4 immunoassay methods report
inconsistent free T4 determinations?
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The following focused unanswered questions have lead to specific experiments:
(1) Are direct free T4 determinations sometimes attributable to serum compounds other
than thyroid hormones (i.e., “blank effects”)? (2) Following equilibrium dialysis and
ultrafiltration, which fraction of serum T4 is most closely related to direct free T4
determinations (ie. retentate, dialysate or ultrafiltrate)? (3) What concentrations of T4 are
most closely related to direct free T4 determinations, when T4 binding serum proteins and
protein bound T4 are not present? (4) What concentrations of T4 are most closely related
to direct free T4 determinations, when T4 binding serum proteins are held constant? (5)
What T4 is most closely related to direct free T4 determinations, when free T4 is held
constant, while T4 binding serum proteins, protein bound T4 and total T4 are varied? (6)
What T4 is most closely related to direct free T4 determinations, when free T4 replaces
protein bound T4 while total T4 concentration is held constant? (7) How do analog-based
free T4 determinations relate to those obtained by direct equilibrium dialysis free T4
assays and total T4 assays?

13

Hypothesis
Our hypothesis is: Direct free T4 immunoassays based on “analogs” of T4 do not
detect and quantify free T4 but detect and quantify protein bound T4, T4 binding serum
proteins and/or total T4. These free T4 methods and the reference methods they are
standardized against must be further characterized.

Objectives and Specific Aims
Our objectives are: A) To investigate the factors involved in free T4
determinations in analog-based free T4 immunoassays. B) To investigate the application
of equilibrium dialysis and ultrafiltration in the separation of free T4 from T4 binding
proteins in human serum. C) To investigate the delayed diffusion of T3 and T4 when
applied to equilibrium dialysis and ultrafiltration.
The specific aims of this dissertation are:
(1) To study dialyzed and ultrafiltered human serum in analog-based free T4
immunoassays.
(2) To determine the contributions of serum proteins and protein bound T4 to analogbased free T4 determinations.
(3) To detect and verify the retention of thyroid hormone binding proteins during
equilibrium dialysis and ultrafiltration.
(4) To characterize the delayed diffusion of thyroid hormones during equilibrium dialysis
and ultrafiltration.
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CHAPTER 2
A DIRECT FREE THYROXINE (T4) IMMUNOASSAY WITH THE
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Abstract

Background: Direct free thyroxine (T4) measurements have been linked to both
T4-binding serum protein concentrations and protein-bound T4 concentrations. Whether
this is evidence of a relationship to total T4 concentrations has not been reported.
Methods: We compared an analog-based direct free T4 immunoassay and a total
T4 immunoassay. Each assay was applied to the fractions of serum T4 obtained by
ultrafiltration and equilibrium dialysis. Both were applied to serum-based solutions in
which free T4, X4-binding proteins, protein-bound T4, and total T4 were systematically
varied, held constant, or excluded.
Results: Neither the free T4 assay nor the total T4 assay detected dialyzable or
ultrafilterable serum T4. Both assays detected and reported the T4 retained with serum
proteins. Both free and total T4 results were related to the same total T4 concentrations in
the presence and absence of T4-binding proteins. Both results were similarly related to
total T4 concentrations when free T4 was held constant while total T4 was varied. Both
were similarly related to a total T4 concentration that was held constant while free T4
progressively replaced protein-bound T4. These free T4 results, like total T4 results, were
unresponsive to a 500-fold variation in dialyzable T4 concentrations.
Conclusion: New experiments extend the characterization of a longstanding and
incompletely characterized analog-based free T4 immunoassay. These free T4
measurements relate to total T4 concentrations in the same way that total T4
measurements do.
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Introduction

Interrelationships among serum free thyroxine (T4), the proteins that bind T4,
protein-bound T4, and total T4 are variable (1-6). Protein-bound and total T4
concentrations vary (correlate) directly with free T4 concentrations when serum T4binding proteins are constant. When free T4 is constant, protein-bound T4 and total T4
concentrations vary directly with concentrations of T4-binding proteins. There are reports
of direct analog-based free T4 results that vary directly with serum concentrations of T4binding protein (7-18) or vary as total T4 concentrations vary (while free T4 is held
constant) (19, 20). These relationships imply that these analog-based direct free T4 assays
detect total T4 concentrations.
This possibility led us to ask the following questions about the direct analogbased free T4 immunoassay. What form of T4 does the assay detect, and what
concentrations of T4 does it measure? Which form of T4 does it detect after equilibrium
dialysis and ultrafiltration? Do the free T4 values correlate with total T4 concentrations
when total T4 is varied (while free T4 is constant) or when total T4 is constant (while free
T4 is varied)?
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Materials and methods

T4 immunoassays
We studied a manual analog-based free T4 immunoassay (Coat-A-Count,
Diagnostic Products Corp.) that uses a radiolabeled T4 analog, immobilized T4 antibody, a
single incubation, and 21-fold dilution with a reagent solution. The total T4 immunoassay
(Coat-A-Count, Diagnostic Products Corp.) uses radiolabeled free T4 (nonanalog),
immobilized T4 antibody, and a single incubation; it is a manual method that dilutes the
solutions it analyzes 41-fold with a reagent solution. Both assays were applied to the
same experimental T4 solutions. The nonanalog free T4 immunoassay (Nichols Institute
Diagnostics) applied to equilibrium dialysates and ultrafiltrates (21-30) uses radiolabeled
free T4, immobilized T4 antibody, and a single incubation; it is a manual method that
dilutes the solutions it analyzes 1.0625-fold with a reagent solution.
We performed each assay according to its manufacturer’s instructions. Each T4
result reported was a mean of triplicates, and each experiment was repeated for
confirmation. We detected and quantified gamma radiation by use of a Gamma 4000
multiwell automated gamma counter (Beckman-Coulter).

Normal human serum
We obtained normal human serum from 16 healthy male volunteers, ages 21 to 55
years. These sera were pooled. Serum collection was approved by the institutional review
board, and serum samples were given anonymous identifiers. In this pool, serum thyroidstimulating hormone (TSH), total T4, free T4, thyroxin-binding globulin (TBG),
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transthyretin (TTR), and albumin were within their respective reference intervals, and test
results for anti-T4, anti-T3, and anti-IgG antibodies and for salicylates were negative
(testing performed at Quest Diagnostics) (data not presented).

T^depleted normal human serum
We stripped an aliquot of the serum pool of T4 using Amberlite IRA-410 anion
exchange resin (Alfa Aesar) (31). No residual total T4 was detected by the total T4
radioimmunoassay, and no dialyzable T4 was detected by the nonanalog free T4
immunoassay. TBG, TTR, and albumin concentrations remained normal after T4
depletion. We estimated the affinity of serum proteins for T4 as the free fraction of serum
T4 (the ratio of dialyzable free T4 to total T4). To measure the free fraction after T4
depletion, T4 was restored to its original concentration. There was no significant change
in affinity after T4 depletion (data not presented).

Sodium levothyroxine
We obtained sodium levothyroxine, for injection, in 500-jag vials (Bedford Labs).
It was dissolved at room temperature in 5 mL of 9 mL/L NaCl, USP grade (Abbott Labs).
This produced a stock solution containing 125 pmol/L (10 000 qg/dL) sodium
levothyroxine.

Equilibrium dialysis
We obtained dialysis devices and dialysate buffer from Nichols Institute
Diagnostics. The chemical composition of this buffer has been reported (27). Serum
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samples were dialyzed for 18 h at 37°C in an Isotemp Incubator, model 630D (Fisher
Scientific). A moisture-saturated atmosphere was maintained during dialysis by enclosing
dialysis cells in containers with open water reservoirs.

Ultrafiltration
We ultrafiltered large volumes of serum (up to 50 mL) under 20 psi nitrogen gas
pressure at 37°C using a stirred ultrafiltration device with a regenerated cellulose
membrane that has a nominal molecular weight cutoff of 12 to 14 kDa (Millipore). We
ultrafiltered small volumes of serum (up to 2 mL) using a Centricon YM-10 ultrafiltration
device with a regenerated cellulose membrane that has a 10-kDa molecular weight cutoff
(Fisher Scientific). Centrifugation at 3000g was carried out at 37°C in a temperaturecontrolled Eppendorf 5702RH centrifuge (Fisher Scientific). All ultrafiltration devices
were prewashed twice with deionized water.

Serum pH control
When dialysis was applied, the pH of serum dialysate and retentate was controlled
to 7.4 (± 0.1) during equilibrium dialysis at 37°C by the HEPES acid in dialysate buffer
(27). At equilibrium, the final HEPES ion concentration was calculated to be 54 mmol/L.
When ultrafiltration was applied, whole serum pH was controlled to 7.4 (±0.1) at
37°C, before ultrafiltration, by adding 40 pL of 1200 mmol/L HEPES acid (Fisher
Biotech) per mL serum. Serum pH stability was obtained during 15 min of vortexing
while passing a continuous stream of moist air across the serum. The final HEPES ion
concentration was 54 mmol/L.
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Free T4 adsorption to container surfaces
Free T4 can adsorb onto solid surfaces from aqueous solutions. We tested the
borosilicate glass vials and test tubes used (Fisher Scientific) for free T4 adsorption by a
modification of the procedure reported by Holm et al. (32). Radiolabeled free T4 (

I-T4;

Perkin Elmer Life Sciences) was freshly repurified by column chromatography before
use, using Sephadex G-25 (Sigma-Aldrich) (33, 34). Columns were equilibrated to 10
mmol/L PBS (1 PBS tablet dissolved in 200 ml of water to obtain: 10 mmol/L phosphate
buffer, 2.7 mmol/L potassium chloride and 137 mmol/L sodium chloride) (SigmaAldrich) at pH 5.4 and room temperature. Stock 125I-T4 was added to the column and
eluted with 100 mmol/L sodium hydroxide (Sigma-Aldrich). We collected fractions in 13
x 100-mm glass test tubes using an automated fraction collector (LKB) and quantified
gamma radiation. The test tubes adsorbed less than 0.4% of free 125I-T4 in the absence of
serum proteins.
We also tested the 2-mL screwcapped glass vials used to store test samples. They
too adsorbed less than 0.4% of free 125I-T4 in the absence of serum proteins. Samples
were stored at -80°C before assay.
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Experimental strategies

We applied the direct free T4 immunoassay and the total T4 immunoassay to the
following solutions:
• Fractions of serum T4 obtained by equilibrium dialysis and ultrafiltration.
• Varied concentrations of sodium levothyroxine added to normal human serum
dialysate (see Materials and Methods) at concentrations of 39 to 309 nmol/L (3 to 24
pg/dL).
• Varied concentrations of sodium levothyroxine added to T4-depleted normal
human serum at concentrations of 39 to 309 nmol/L (3 to 24 pg/dL). The dialyzable T4 in
these solutions (direct equilibrium dialysis) was 7.7 to 125 pmol/L (0.6 to 9.7 ng/dL).
• Varied concentrations of serum proteins, protein-bound T4, and total T4 while
free T4 concentration remained constant. Ultrafiltration was applied to normal serum.
One aliquot of retentate was undiluted. Other aliquots were diluted 2-fold, 4-fold, and 8fold with the corresponding ultrafiltrate. Thus, serum proteins, protein-bound T4, and
total T4 were varied from a low of 25% of native serum concentrations to a high of 200%
of native serum concentrations, while free T4 was constant. We confirmed the variation in
total T4 concentrations by measuring total T4, the variation in protein concentrations by
measuring total protein and transthyretin (Quest Diagnostics) (data not presented), and
the constancy of free T4 concentration by measuring dialyzable T4 (data not presented).
T4-depleted serum proteins were varied in the same way.
• Varied concentrations of serum proteins and protein-bound T4 progressively replaced
with free T4 while total T4 was held constant. We applied equilibrium dialysis to normal
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serum. We measured the total T4 in retentate using the total T4 immunoassay (Table 2.1)
and added sodium levothyroxine solution to the dialysate to match the concentration of
total T4 in the retentate. The retentate was progressively diluted with T4-enriched
dialysate until dialyzable T4 concentrations reached a plateau. We measured dialyzable T4
by use of nonanalog free T4 immunoassay (see Methods and Materials). High dialyzable
T4 concentrations were diluted with immunoassay zero calibrator, as needed, to bring
them into the interval quantified by the nonanalog free T4 immunoassay (2.6 to 129
pmol/L). These dialyzable T4 measurements varied from 16.7 to 8940 pmol/L (1.3 to 693
ng/dL) (Fig. 2A).

Results

Neither the analog-based direct free T4 immunoassay nor the total T4
immunoassay detected ultrafilterable or dialyzable serum T4. Both assays detected and
quantified the T4 retained with serum proteins during dialysis and ultrafiltration. The
nonanalog free T4 immunoassay was the only assay that detected and quantified
ultrafilterable and dialyzable serum T4 (Table 2.1).
When T4 was added to normal human serum dialysate at concentrations of 39 to
309 nmol/L (3 to 24 pg/dL), the direct free T4 values were 9 to 81 pmol/L (0.7 to 6.3
ng/dL) and the total T4 values were 30 to 257 nmol/L (2.3 to 20 pg/dL) (Table 2.2).
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When T4 was added to T4-depleted normal human serum at concentrations of 39
to 309 nmol/L (3 to 24 pg/dL), the direct free T4 values were 6 to 71 pmol/L (0.5 to 5.5
ng/dL) and the total T4 values were 40 to 257 nmol/L (3.1 to 20 pg/dL) (Table 2.3).
When serum protein concentrations, protein bound T4 concentrations, and total T4
concentrations were varied from 25% to 200% of whole serum concentrations while free
T4 was constant, the direct free T4 values varied from 2.6 to 34.8 pmol/L (0.2 to 2.7
ng/dL) and the total values varied from 21.9 to 139 nmol/L (1.7 to 10.8 pg/dL) (Fig. 1)
(Standard deviations reported by error bars).
When free T4 progressively replaced protein bound T4 while total T4 was
constant, both analog-based direct free T4 measurements and total T4 measurements were
closely related to total T4 concentration (Fig. 2B and C). Neither the analog-based direct
free T4 assay nor the total T4 assay detected or followed the variation in dialyzable T4
concentrations when they varied from 16.7 to 8940 pmol/L (1.3 to 693 ng/dL) (Fig. 2A).
The mean total T4 result was 77.5 nmol/L (6.0 pg/dL) (Fig. 2C). The mean free T4 result
was 18.6 pmol/L (1.4 ng/dL) (Fig. 2B).
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Table 2.1 Serum T4 fractions obtained by equilibrium dialysis and ultrafiltration
applied to three T4 assays.
The four fractions obtained by equilibrium dialysis and ultrafiltration were applied to one
total T4 assay, one direct analog-based free T4 assay and one direct free T4
radioimmunoassay. The direct analog-based free T4 assay detects the same fractions of
serum T4 that the total T4 assay detects
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Table 2.1 Serum fractions and T4 values.
Equilibrium Dialysis
Ultrafiltration
Dialysate
Retentate
Ultrafiltrate
Immunoassays
Retentate
ND
77 nmol/L
ND
139 nmol/L
Total T4
ND
17
pmol/L
ND
pmol/L
34.7
Analog Free T4
>129pmol/L
19pmol/L
Non Analog Free T4 >129 pmol/L 20.6 pmol/L
ND = not detected: total T4 <12.87 nmol/L or free T4 <1.29 pmol/L
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Table 2.2 T4 added to serum dialysate and applied to a total T4 assay and a direct
analog-based free T4 assay.
An analog-based free T4 immunoassay parallels a total T4 immunoassay in the absence of
T4 binding serum proteins
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Table 2.2 Results when T4 was added to serum dialysate.
Total T4
Analog-based Free T4
T4 Added
(nmol/L)
(pmol/L)
(nmol/L)

39
77
116
154
193
232
270
309
Mean

30
60
104
130
176
196
229
257
148

9
21
33
44
54
66
79
81
48

T4: 1 (xg/dL = 12.87 nmol/L
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Table 2.3 T4 added to T4-depleted serum and applied to a total T4 assay and a direct
analog-based free T4 assay.
An analog-based free T4 immunoassay parallels a total T4 immunoassay in the presence
of T4 binding serum proteins.
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Table 2.3 Results when T4 was added to T4 depleted serum.
Analog-based Free T4
T4 Added
Total T4 (nmol/L)
(pmol/L)
(nmol/L)

39
77
116
154
193
232
270
309
Mean

6
14
23
32
39
51
58
71
37

T4: 1 ng/dL = 12.87 nmol/L
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40
76
112
139
169
199
241
257
154

Figure 2.1 Free T4 is constant: proteins, protein bound T4 and total T4 vary.
Comparison of analog-based free T4 estimates to total T4 determinations. Free T4
concentration was held constant at 20 pmol/L (1.6 ng/dL). The concentrations of serum
proteins, protein bound T4 and total T4 were varied from 25%, 50%, 100% and 200% of
those in whole serum.
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-50
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0

Total T4
Values
(nmol/L)

Figure 2.2 Total T4 constant: proteins, protein bound T4 and free T4 vary.
Assay responses to replacement of protein bound T4 by free T4, while holding total T4
constant. (A) Dialyzable T4 values by nonanalog free T4 RIA, (B) direct free T4 values by
analog-based free T4 RIA, and (C) total T4 values.
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Discussion

The primary reason for carrying out free T4 measurements is to differentiate
patients with unusual or abnormal serum free T4 concentrations from patients with
unusual or abnormal T4 binding to serum proteins. When T4 binding to serum proteins is
normal (or constant), total T4 measurements will be proportional to free T4
concentrations, and both will be categorically similar (low, normal, or high) (see Table
2.3). This is not the situation when free T4 concentrations are constant (or similar) and T4
binding serum protein concentrations (or affinities) are unusual or abnormal. Under these
conditions, dialyzable T4 concentrations will have a different relationship to total T4
concentrations (16, 19, 35, 36).
The data obtained with these experiments document a direct analog-based free T4
immunoassay that reports free T4 values with the characteristics of total T4 values, but
each assay’s calibration is strikingly different. The direct free T4 immunoassay did not
follow normal free T4 concentrations in the presence of varied total T4 concentrations
(Figure 2.1) or abnormal free T4 concentrations when total T4 was normal (Figure 2.2).
The information provided by this direct free T4 immunoassay is qualitatively similar to
the information provided by total T4 immunoassays. There is no evidence that this free T4
immunoassay will be more useful than a total T4 immunoassay.
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Abstract

Background: Direct equilibrium dialysis and direct ultrafiltration-free thyroxine (T4)
assays rely on semipermeable membranes to exclude T4-binding serum proteins from
dialysates and ultrafiltrates. The presence of these proteins in dialysates or ultrafiltrates
will yield spuriously high free T4 values when free T4 is quantified by RIA.
Methods: We used a nonanalog free T4 RIA that detects and quantifies dialyzable and
ultrafilterable serum free T4 to detect T^-binding serum proteins. Two equilibrium
dialysis devices and 3 ultrafiltration devices were used to illustrate this application.
Displacements of 125I-T4 from anti-T4 by various concentrations of T4-depleted TBG,
albumin, and serum total protein were compared to displacements by various
concentrations of free T4.
Results: Both dialysis devices excluded detectable T4-binding serum proteins from
dialysates. Two of 3 ultrafiltration devices excluded detectable T4-binding serum proteins
from ultrafiltrates. One did not. This ultrafiltrate yielded spurious free T4 values that
correlated directly with serum protein concentrations.
Conclusion: The presence or absence of T4-binding proteins in dialysates and
ultrafiltrates, and the spurious free T4 values that these proteins cause, can be documented
using a nonanalog free T4 RIA.
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Introduction

Direct equilibrium dialysis free T4 assays and direct ultrafiltration free T4 assays
use semi-permeable membranes to separate free T4 from T4 binding serum proteins (112). Non-analog free T4 immunoassays are widely used to quantify this X4. These free T4
assays are radioimmunoassays (RIAs) based on the binding of 125I-T4 to anti-T4, and
displacements of 125I-T4 from anti-T4 by unlabeled T4 (13-15). This is illustrated in Figure
3.1 A.
When T4 binding serum proteins (T4BSPs) are present in dialysates or
ultrafiltrates they spontaneously bind 125I-T4 and displace it from anti-T4. These assays do
not distinguish displacements by protein from displacements by T4. As a consequence,
spurious free T4 determinations are reported by the assay in the absence of T4, and
spurious overestimates of T4 are reported when T4 is present. These interactions are
illustrated in Figure 3.1 B.
The spurious free T4 determinations attributable to T4BSP, and the concentrations
of T4BSP that account for them, have not been reported. The present study reports the
experiments that provide these data.
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Materials and methods

Non-analog free T4 RIA
The same non-analog free T4 immunoassay (Nichols Institute Diagnostics) was
used to detect and quantify free T4 in the absence of T4BSP, and to detect T4BSP in the
absence of T4. This assay has been reported previously (1).

The human serum albumin and human serum TBG to which the free T4 RIA was applied.
Highly purified human serum albumin (> 99%, Sigma-Aldrich) and TBG (> 95%,
Cortex Biochem) were each dissolved in T4 depleted normal human serum dialysate (see
below) at room temperature. Albumin (200 g/L) was diluted with T4 depleted human
serum dialysate to concentrations ranging from 2xl0"2 to 200 g/L. TBG (60 mg/L) was
diluted with T4 depleted human serum dialysate to concentrations ranging from 6x10 '5 to
60 mg/L. T4 was not detected in these protein preparations when a total T4 RIA
(Diagnostic Products Corporation) was applied, or in the dialysates of these solutions,
when the non-analog free T4 RIA was applied.

The T4 depleted serum total protein to which the free T4 RIA was applied
A pool of normal human serum was obtained (Equitech-Bio) and characterized.
Serum TBG (17 mg/L), transthyretin (0.27 g/L), albumin (42 g/L), total protein (86 g/L),
total T4 (94 nmol/L, 7.3 ug/dL), free T4 (12.9 pmol/L, 1.0 ng/dL) and TSH (2.15 MIU/L)
were within their respective reference ranges. Anti-T4, anti-Ta, anti-IgG and salicylates
were not detected (Quest Diagnostics).
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An aliquot of this serum was stripped of T4 using the method of Grundy, et al
(16). T4 depleted serum total protein concentrations were varied from 5xl0"7 to 0.05 g/L
by diluting T4 depleted serum total protein (86 g/L) with T4 depleted human serum
dialysate.

The T4 depleted serum total protein to which equilibrium dialysis and ultrafiltration were
applied.
T4 depleted serum total protein (86 g/L) was concentrated to 160 g/L by
ultrafiltration, under 25 psi nitrogen gas pressure at 37 °C, using a 50 mL stirred
ultrafiltration cell, with a regenerated cellulose membrane that has a nominal molecular
weight cut-off (MWCO) of 12-14 kDa (Millipore). (No T4BSPs were detected in this
serum ultrafiltrate, data not presented). Retentate and ultrafiltrate were then mixed to
obtain additional total protein concentrations of 40, 80 and 120 g/L. In this way, total
protein concentrations were varied from 40-160 g/L.

Dialysis
Two dialysis devices were studied; a vertical membrane dialysis device (Fisher
Scientific) using 10 mL of retentate and 10 mL of dialysate, and a horizontal membrane
dialysis device using 200 pL of retentate and 2400 pL of dialysate (Nichols Institute
Diagnostics). The dialysis buffer (Nichols Institute Diagnostics) has been reported
previously (1). Both devices used a regenerated cellulose membrane (Spectra/Por, Fisher
Scientific) with a MWCO of 12-14 kDa. T4 depleted serum total protein was dialyzed for
18 hours at 37 °C in an Isotemp incubator (model 630D, Fisher Scientific). During
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dialysis, pH was controlled to 7.4 (±0.1) at 37 °C (in both retentates and dialysates) by
the HEPES ion contained in the dialysis buffer (see above). The final HEPES
concentration was 54 mM (1).

Ultrafiltration
Three ultrafiltration devices were tested; Centricon YM-10, Centricon YM-30 and
Amicon Ultra-4 (Millipore). These devices have reported MWCOs of 10 kDa, 30 kDa
and 10 kDa, respectively. A fourth device, Centricon YM-100 (Millipore) with a reported
MWCO of 100 kDa, was used as a positive control, since T4BSPS have molecular
weights of approximately 54-66 kDa. The semi-permeable membrane in each device was
made of regenerated cellulose.
Centrifugation was carried out in a temperature controlled, fixed-angle rotor
ultracentrifuge (5702 RH, Eppendorf AG) at 37 °C. The pH was controlled prior to
ultrafiltration to 7.4 (±0.1) at 37 °C by adding 40 pL of 1200 mM HEPES acid (Fisher
Biotech) per mL of serum. The pH was stabilized during 15 minutes of vortexing while
passing a continuous stream of moist air across the serum. The final HEPES ion
concentration was 54 mM (1).

Sodium levothyroxine
Sodium levothyroxine (for injection) was obtained in 500 pg vials (Bedford Labs)
and dissolved in 5 mL of 0.9% sodium chloride, USP grade (Abbott Labs), at room
temperature. This provided a T4 stock solution containing 125 pmol/L (10 mg/dL)

47

sodium levothyroxine. Aliquots were diluted with T4 depleted human serum dialysate to
concentrations of 2.6 x 10‘5 to 26 nmol/L (2xl0’3 to 2000 ng/dL).

The possibility offree T4 losses due to adsorption
Free T4 is often adsorbed from aqueous solutions onto solid surfaces. Borosilicate
glass test tubes and borosilicate glass screw-capped vials (Fisher Scientific, Pittsburgh,
PA) were tested for 125I-T4 adsorption by a modification of the procedure reported by
Holm, et al (17). 125I-T4 (125I-T4, Perkin Elmer Life Sciences) was purified using
Sephadex G-25 (Sigma-Aldrich) column chromatography (18, 19). The Sephadex
columns were equilibrated to 0.01 M PBS (Sigma-Aldrich), at pH 5.4 and room
temperature. Stock 125I-T4 was added to the column and eluted with 100 mM sodium
hydroxide (Sigma-Aldrich). Fractions were collected in 13x100 mm glass test tubes using
an automated fraction collector (LKB). Gamma radiation was quantified using a multi
well, automated gamma counter (Gamma 4000, Beckman-Coulter). These test tubes, and
the 2 mL screw-capped glass vials used for storage, adsorbed less than 0.4% of free
T4 dissolved in human serum dialysate. T4 solutions were stored at -80°C.
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Results

The displacements of 125I-T4 from anti-T4 by varied concentrations of T4-depleted
TBG, albumin, and serum total protein are compared to the displacements by varied
concentrations of free T4 (in the absence of T4BP) (Figure 3.2). A dialysate of T4 depleted
human serum was used as the negative control. A theoretical lower limit for the detection
of displacements was calculated as the mean minus two standard deviations of the
negative control. These values were 0.001 mg/L for T4 depleted TBG, 0.025 g/L for T4
depleted albumin and 0.0015 g/L for T4 depleted total protein. This compares to 0.8
pmol/L for free T4 (Table 3.1). Fifty percent displacements of 125I-T4 from anti-T4 were
obtained with T4 depleted TBG at 0.028 mg/L, T4 depleted albumin at 0.76 g/L and T4
depleted serum total protein at 0.038 g/L. This compares to free T4 at 34 pmol/L (Table
3.2).

When T4 depleted TBG concentrations were 0.01%, 0.1% and 1.0% of whole
serum levels (0.0017, 0.017 and 0.17 mg/L), labeled T4 displacements were equivalent to
free T4 concentrations of 3, 30 and 300 pmol/L (0.23, 2.3 and 23 ng/dL). When T4
depleted albumin concentrations were 0.01%, 0.1% and 1.0% of whole serum levels
(0.0042, 0.042 and 0.42 g/L), labeled T4 displacements were equivalent to free T4
concentrations of 0.3, 3 and 30 pmol/L (0.023, 0.23 and 2.3 ng/dL). When T4 depleted
serum total protein concentrations were 0.01%, 0.1% and 1.0% of whole serum levels
(0.86, 8.6 and 86 g/L), labeled T4 displacements were equivalent to unlabeled T4
concentrations of 3.9, 39 and 390 pmol/L (0.3, 3 and 30 ng/dL).
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As a percent of whole serum concentrations, T4 depleted serum total proteins
were as effective or marginally more effective in displacing 125I-T4 than T4 depleted TBG
concentrations, and were more effective than T4 depleted albumin concentrations (Tables
3.1 and 3.2). We chose T4 depleted serum total protein to test for spurious free T4
determinations in dialysates and ultrafiltrates because it contains all T4BSP.
No spurious free T4 determinations were obtained with either dialysis device.
Spurious free T4 determinations were obtained with one of three ultrafiltration devices
(Figure 3.3). These free T4 determinations correlated with the concentrations of serum
total protein in the solutions to which ultrafiltration was applied (r2 = 0.97, p<0.02).
These data are striking, because the designated molecular weight cut-off for this device
was 10 kDa, well below the molecular weights of T4BSPS. Spurious free T4
determinations, due to protein leakage, were obtained with the positive control (Figure
3.3) and none were obtained with a negative control (see results).

50

Table 3.1 Minimum displacements of 125I-T4 from anti-T4.
The minimum displacements, determined as the mean minus two standard deviations
from the negative control, were determined for T4 Depleted TBG, albumin, total serum
proteins and free thyroxine.
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Table 3.1 Minimum displacements of 125I-T4 from anti-T4.
T4BSP as portion of
T4BSP concentrations
normal concentration
0.005
0.001
g/L
T4 Depleted TBG
0.05
0.025 g/L
T4 Depleted Albumin
0.002
0.0015 g/L
T4 Depleted Total Protein
0.001
0.8 pmol/L
Free T4
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Table 3.2 Fifty percent displacements of 125I-T4 from anti-T4.
The fifty percent displacements were determined for T4 Depleted TBG, albumin, total
serum proteins and free thyroxine.
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Table 3.2 Fifty percent displacements of 125I-T4 from anti-T4.
Percent of normal
Concentrations
serum concentrations
0.14
0.028 mg/L
T4 Depleted TBG
1.65
0.76 g/L
T4 Depleted Albumin
0.05
0.038 g/L
T4 Depleted Total Protein
0.05
34
pmol/L
Free T4
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Figure 3.1 A direct free T4 RIA
Interactions of unlabeled T4 (A) and T4 binding serum proteins (B) in a non-analog free
T4 RIA
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Figure 3.2 Comparison of displacements in a free T4 RIA.
I-T4 displacements from anti-T4 in a non-analog free T4 RIA obtained with; ♦ free T4,
□ T4 depleted TBG, A T4 depleted serum total proteins and, o T4 depleted albumin. The
upper horizontal solid line represents maximum binding obtained with the negative
control. The dash-dot line represents the lower 95% confidence limit of the negative
control data.
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Figure 3.3 Protein retention in equilibrium dialysis and ultrafiltration.
Dialysis and ultrafiltration devices applied to 40, 80, 120 and 160 g/L of X4-depleted
serum total proteins. No spurious free T4 determinations were obtained with 2 dialysis
devices (A & B). None were obtained with 2 ultrafiltration devices (C & D). Spurious
free T4 determinations of 9 to 102 pmol/L (7 to 79 ng/L) were obtained using a 3rd
ultrafiltration device with a designated MWCO of 10 kDa (E). Spurious free T4
determinations of 102 to 165 pmol/L (79 to 128 ng/L) were obtained with the positive
control, an ultrafiltration device with a designated MWCO of 100 kDa (F). (* denotes not
detected) Ultrafiltration devices: (C) Centricon YM-10, (D) YM-30, (E) Amicon Ultra-4
and (F) Centricon YM-100.
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(E) Amicon Ultra-4. (F) Centricon YM-100.

60

Discussion

Previous studies have measured albumin in serum dialysates or ultrafiltrates.
Weeke et al. measured albumin in serum ultrafiltrates using a microalbuminuria RIA with
a sensitivity of 0.001 g/L (20, 21). They concluded that an albumin leakage of 0.0015%
of undiluted serum albumin would induce an error of approximately 5% in free T4
determinations. Using our assay, the presence of 0.05% (0.025 g/L) of serum albumin in
ultrafiltrate resulted in spurious free T4 values of approximately 3% (0.5 pmol/L).
Tikanoja, et al. measured albumin in serum ultrafiltrates using an albumin RIA
with a sensitivity of 8.0 x 10'4 g/L (22). The study used a cutoff value for protein leakage
of 0.005% of serum proteins as reported by Weeke, et al (20). Ultrafiltration devices that
allowed less than this 0.005% (0.002 g/L) of albumin into ultrafiltrates were regarded as
acceptable. Only one device out of four met this criterion. Again, this compares to our
assay where 0.05% (0.025 g/L) of serum albumin in ultrafiltrate resulted in spurious free
T4 values of approx. 3% (0.5 pmol/L).
Holm, et al. measured albumin in serum dialysates and serum ultrafiltrates using a
double antibody sandwich ELISA with a sensitivity of 2.8 x 10"6 g/L (23). They found no
detectable albumin in serum dialysates, and detectable albumin in the ultrafiltrates
obtained with each of five ultrafiltration devices.
These previous studies used albumin assays that were more sensitive for the
detection of albumin than the free T4 RIA used in the present study (0.001 g/L, 8.0 x 10
g/L and 2.8 x 10'6 g/L, compared to 0.025 g/L). However, the free T4 RIA detected and
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-4

quantified the interference by albumin, and therefore provides the most relevant data
regarding protein interference in free T4 determinations.
Intralot and interlot variations in the retentive characteristics of the same
ultrafiltration devices are another issue (22, 23). This was evident in our positive control
(Figure 3.3).
There are no previous studies reporting the spurious free T4 determinations that
result from the presence of T4BSPS in serum dialysates or ultrafiltrates. Any laboratory
with a free T4 RIA that detects and quantifies T4 in serum dialysates or serum
ultrafiltrates has the ability to detect spurious free T4 values due to T4BSP in dialysates
and ultrafiltrates. Testing for T4BSP interferences could easily be a routine part of quality
control in any published data reporting dialyzable or ultrafilterable free T4
determinations. In our opinion, it should always be included in a study reporting
inconsistencies between dialysis based free T4 determinations and ultrafiltration based
free T4 determinations (24). Without this information, it will be uncertain whether
disparities in free T4 determinations represent a serum problem or an assay problem.
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Abstract

Background: Ultrafiltration has been regarded as a “standard” method for the separation
of free thyroid hormones from serum proteins and protein bound thyroid hormones. This
application of ultrafiltration is understood to yield equal concentrations of free hormones
in aqueous solutions on opposite sides of a semi-permeable membrane. The present study
was undertaken to document this equality. We found unequal concentrations instead of
equal concentrations.
Design: 3H20, 125I-T3 and 125I-T4 were dissolved in separate aliquots of pH controlled
normal human serum ultrafiltrate. Four ultrafiltration devices were applied to each
solution. The movement of labeled water across semi-permeable membranes was
compared to the movement of labeled free hormones in this biologically relevant protein
free solution.
Results: There was wide variability in the movement of free T3 and free T4 across semipermeable membranes. Variability was dependent upon the device used and the progress
of ultrafiltration. There was also variability in the recovery of free hormones from
ultrafiltration devices. The loss of T3 was up to 75% ±0.6 and the loss of T4 was up to
56% ±1.7.
Conclusion: These variabilities complicate the interpretation of free thyroid hormone
measurements involving ultrafiltration.
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Introduction

Ultrafiltration has been regarded as a “standard” method for separating free T3
and free T4 from serum proteins and protein bound hormone (1-6). It is expected that free
T3 and free T4 in aqueous solutions will accompany water as water moves across semipermeable membranes. This would result in equal concentrations of free T3 and free T4 in
the two aqueous solutions on opposite sides of semi-permeable membranes following
ultrafiltration. The movements of free thyroid hormones through semi-permeable
membranes have not been compared to the movement of water, nor have the
concentrations of free hormones on opposite sides been determined in the absence of
hormone binding proteins. This is a report of experiments undertaken to determine the
movements of 3H20, 125I-T3 and 125I-T4 across semi-permeable membranes in four
different types of ultrafiltration devices using a biologically relevant aqueous solution
after excluding serum proteins.
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Materials and methods

Serum ultrafiltrate
A pool of normal human serum was obtained from Equitech-Bio. Serum
thyroxine binding globulin (TBG), transthyretin (TTR), albumin, total protein, total T4,
dialyzable (free) T4 and thyroid stimulating hormone (TSH) were within their respective
reference intervals. Test results for anti-T4, anti-Ta anti-IgG and for salicylates were
negative (testing performed at Quest Diagnostics). Serum pH was controlled at 7.4 by
adding HEPES acid to a final concentration of 54 mM (7).
Ultrafiltrate was obtained from 50 mL of this serum by applying 25 psi of
nitrogen gas pressure at 37°C to a stirred ultrafiltration device with a regenerated
cellulose membrane that has a 10-kDa molecular weight cutoff (Millipore). Ultrafiltration
was continued until the volume of retentate and ultrafiltrate were equal. Serum proteins
were not detected in this ultrafiltrate (data not presented).

Solutions of isotope labeled water, T3 and T4
Radiolabeled water (3H2G), triiodothyronine (125I-T3) and thyroxine (125I-T4) were
obtained from PerkinElmer Life Sciences. 3H20 was quantified using an automated liquid
scintillation counter (Beckman LS 7500, Beckman Coulter). 125I-T3 and 125I-T4 were
quantified using an automated gamma counter (Gamma 4000, Beckman Coulter).
Routine checks were performed to maintain precision, accuracy and counting efficiency.
Prior to each experiment, 125I-T3 and 125I-T4 were purified using Sephadex G-25
(Sigma-Aldrich) column chromatography as previously described (8). These freshly
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purified radiolabeled analytes (125I-T3 and 125I-T4) and the 3H20 were added to different
aliquots of the same serum ultrafiltrate at room temperature.

Tj and T4 adsorption to glassware
T3 and T4 can be adsorbed onto solid surfaces from aqueous solutions. The
borosilicate glassware used in this study (Fisher Scientific) was tested for T3 and T4
adsorption by a modification of the procedure reported by Holm, et al (9).

I-T3 and

,25I-T4 were purified (see above) and used within an hour of purification. Less than 0.7%
of 125I-T3 and less than 0.4% of 125I-T4 was adsorbed in the absence of serum proteins.
Water, T3 and T4 diffusion during ultrafiltration
The four ultrafiltration devices studied (Millipore) were: Centricon YM-10, YM30 and YM-100 (10-kDa, 30-kDa and 100-kDa MWCO) and Amicon Ultra-4 (10-kDa
MWCO). All devices used regenerated cellulose membranes. Devices of each type were
3

applied to aliquots of serum ultrafiltrate containing H2O,

125

I-T3 or

125

r

I-T4 and

ultrafiltered at 37°C in a temperature controlled centrifuge at 3000 x g (5702RH,
Eppendorf). Samples containing one of the radiolabeled compounds were ultrafiltered
until 25%, 50% or 75% of the aqueous solution had passed through the membrane, using
a separate device for each percentage. Each experiment was performed twice in triplicate.
Ultrafiltrates were transferred to 12 x 75 borosilicate glass test tubes (Fisher Scientific).
The radioactivity (cpm/200 pL) was determined for each retentate and ultrafiltrate
solution. The radioactive stock solutions were used as controls.
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Determining the progress of water across semi-permeable membranes
In each experiment, the progress of ultrafiltration to 25%, 50% and 75% was
determined gravimetrically. Each ultrafiltration device was rinsed with deionized water,
shaken to remove excess water and weighed. The sample was placed into the retentate
chamber and the device compartments were weighed again. Ultrafiltration was
performed. The progress of ultrafiltration was determined by weighing each retentate and
ultrafiltrate compartment. Ultrafiltration to 25%, 50% and 75% was defined as the
percent of water mass that crossed the membrane. The time necessary to accomplish this
was determined in pilot studies.

Determining the loss of radiolabeled compounds during ultrafiltration
After ultrafiltration was discontinued, the loss of radiolabeled compounds
(cpm/200 pL) was determined for each retentate and ultrafiltrate. Retentate and
ultrafiltrate radioactivities were averaged together and divided by the radioactivities of
controls to calculate the percentage of radiolabeled compound lost during ultrafiltration.
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Results

The concentration of 3H20 was evenly distributed between retentates and
ultrafiltrates in all four ultrafiltration devices (Figure 4.1 A-D). The concentrations of
125I-T3 and l25I-T4 were unevenly distributed between retentates and ultrafiltrates in all
four ultrafiltration devices (Figure 4.1 A-D).
The losses of radiolabeled compounds during ultrafiltration are reported (Table
4.1). The losses of 3H20 were trivial. The losses of 125I-T3 declined as ultrafiltration
progressed. The losses of 125I-T4 declined as ultrafiltration progressed. It is important to
note that 3H20,125I-T3 and 125I-T4 were dissolved in normal human serum ultrafiltrate
containing normal levels of serum electrolytes and free thyroid hormones.
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Tables 4.1 A-C. Losses of radiolabeled compounds related to the progress of
ultrafiltration among ultrafiltration devices as a percent of control (cpm/200 pi).
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Table 1 A. Percent
YM-10
YM-30
YM-100
Ultra-4

lost

50%
0.3 ±0.8
0.6 ±1.4
2.1 ±2.2
1.7 ±0.7

25%
1.6 ±1.2
1.0 ±1.1
-0.7 ±3.5
0.2 ±1.1

75%
2.0±0.9
2.1±1.1
0±1.6
2.5±1.0

YM-10
YM-30
YM-100
Ultra-4

Table IB. Percent 125I-T3lost
50%
25%
9.6 ±0.9
9.6 ±1.5
8.6 ±1.3
7.7 ±1.2
44 ±2.2
40 ±1.4
74 ±0.8
75 ±0.6

YM-10
YM-30
YM-100
Ultra-4

Table 1C. Percent 125I-T4lost
50%
75%
25%
12 ±1.8
4.7±1.6 0 ±2.2
9.0 ±4.6
1.8±2.9 -8.4 ±5.1
34 ±1.8
31±0.9 27 ±1.1
56 ±1.7
56±0.9 53 ±2.4

75

75%
6.6 ±1.9
-3.7±3.1
36±2.2
69±1.2

Figure 4.1 3H20, 125I-T3and 125I-T4 applied to four ultrafiltration devices in the
absence of serum proteins. Unequal concentrations of radiolabeled T3 and T4, shown as
a percent of control (y-axis), were related to the mass of water that moved across semipermeable membranes during the progress of ultrafiltration (x-axis). The radiolabeled
compounds were dissolved separately in pH controlled normal human serum ultrafiltrate,
before the experimental ultrafiltration. The devices were: (A) YM-10, (B) YM-30, (C)
YM-100 and (D) Ultra-4. (BRetentate and ■ Ultrafiltrate)
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Discussion

The application of various ultrafiltration devices to radiolabeled water, T3 and T4
yielded striking inconsistencies (Fig. 1 A-D). The differences in hormone concentrations
on opposite sides of semi-permeable membranes and the magnitudes of hormone losses
during ultrafiltration were unexpected.
A recent study by the authors documented inconsistency in the retention of serum
proteins by these same devices (10). The present study confirms the findings of the
previous study; ultrafiltration is complex, poorly characterized and incompletely
understood. The movement of water, T3 and T4 across semi-permeable membranes could
not be predicted based on the reported molecular weight cutoff. These inconsistencies
complicate the interpretation of previous free thyroid hormone measurements involving
uncharacterized ultrafiltration.
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Introduction
The thyroid hormones in serum, triiodothyronine (T3) and thyroxine (T4), exist in
two forms: protein-bound and unbound (free). For decades, widely accepted reference
methods for the quantification of free thyroxine have been direct equilibrium dialysis
radioimmunoassays (RIA) (Nelson 1988, Helenius 1983, Weeke 1978). These methods
are based on the separation of free T4 from serum proteins and protein bound T4 using
equilibrium dialysis. A lack of scientific evidence characterizing the diffusion of free
thyroid hormones during equilibrium dialysis has led us to ask the following questions:
Do free T3 and free T4 diffuse across semi-permeable membranes at the same rate? How
do the diffusion rates of free T3 and free T4 compare to the diffusion rate of water? Does
the volumetric ratio of retentate to dialysate have an effect on the time-to-equilibrium of
water, free T3 and free T4? And, will the presence of normal serum proteins in the sample
have an effect on the time-to-equilibrium of water, free T3 and free T4?
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Materials and methods
Serum dialysate
A pool of normal human serum was obtained (Equitech-Bio) and characterized.
Serum TBG, transthyretin, albumin, total protein, total T4, free T4 and TSH were within
their respective reference ranges, and anti-T4, anti-Ts^ anti-IgG and salicylates were
negative (Quest Diagnostics).
Normal serum dialysate was obtained by dialyzing 200 pL of this serum against
2400 pL of dialysis buffer. Dialysis cells and dialysate buffer were obtained (Nichols
Institute Diagnostics) and have been previously described (Nelson 1988). Dialysis was
performed in a moisture saturated atmosphere (greater than 90% humidity) at 37°C for 18
hours using a regenerated cellulose membrane of 12-14 kDa molecular weight cutoff
(MWCO) (Millipore).

Isotope labeled Water, T3 and T4
Radiolabeled water (3H2G), triiodothyronine (125I-T3) and thyroxine (125I-T4) were
obtained (PerkinElmer Life Sciences). 3H20 was quantified using an automated liquid
scintillation counter (Beckman LS 7500, Beckman Coulter). 125I-T3 and 125I-T4 were
quantified using an automated gamma counter (Gamma 4000, Beckman Coulter).
Routine background checks were performed on these instruments to maintain precision,
accuracy and counting efficiency.
Radiolabeled T3 and T4 are known to undergo radiolytic degradation, forming
radiolabeled impurities. Prior to each experiment, radiolabeled T3 and T4 were purified as
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previously described (Fritz 2007). Each of the three, high purity, radiolabeled analytes
(3H20, 125I-T3 and 125I-T4) was added, individually, to normal serum dialysate.

Water, T3 and T4 Diffusion in Dialysis
The solutions of 3H20,125I-T3 and 125I-T4 were each dialyzed against normal
serum dialysate. Three dialysis devices were studied: A vertical membrane dialysis
device applied to 10 mL of sample retentate and 10 mL of dialysate (Fisher Scientific), a
horizontal membrane dialysis device applied to 200 uL or 600 uL of sample retentate and
2400 pL of dialysate (Nichols Institute Diagnostics) and a vertical membrane dialysis
device applied to 200 uL of sample retentate and 1400 pL of dialysate (Quest Diagnostics
Reference Labs). Spectra/Por regenerated cellulose membrane (Fisher Scientific) with a
12-14 kDa MWCO, was used in all devices. Samples were dialyzed at 37°C in an
Isotemp Incubator, Model 630D (Fisher Scientific). Each of the 4 selected dialysis
methods (3 devices) were applied separately to the solutions of H20,

I-T3 and

I-T4.

In one method, the three analytes were added, individually, to an aliquot of the
normal serum and were dialyzed against normal serum dialysate.

T3 and T4 adsorption to glassware
T3 and T4 can be adsorbed onto solid surfaces from aqueous solutions. The
borosilicate glassware used in this study (Fisher Scientific) was tested for T3 and T4
adsorption as previously described (Fritz 2007). Less than 0.7% of 125I-T3 and less than
0.4% of 125I-T4 was adsorbed in the absence of serum proteins.
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Results
The diffusion of 3H20 was 5 to 8 times more rapid than the diffusions of free T3
and free T4, varying with the volumes of aqueous solutions (Figure 5.1). In the absence of
serum proteins, the diffusions of 3H20,125I-T3 and 125I-T4 during equilibrium dialysis
were determined, in triplicate, for each of the four dialysis methods. Dialysis was
monitored until equilibrium was reached (Table 5.1). In all four of the dialysis methods,
no apparent differences exist between the delayed diffusion of T3 and of T4.
In one dialysis method, 200 uL retentate and 2400 uL dialysate, the three analytes
were applied in the absence of serum proteins as well as in the presence of serum
proteins. Normal levels of serum proteins in the retentate had no affect on the diffusion
rate of 3H20 (Figure 5.2). However, the presence of serum proteins delayed the diffusion
of thyroid hormones from 12 hours to 18 hours, resulting in a 50% increase in the time
required to reach equilibrium (Figure 5.2).
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Table 5.1 Time (in hours, at 37° C) before equilibrium is reached for
H2O, free T3 and free T4 when retentate and/or dialysate volumes differ.
Determined in the absence3 and presence5 of normal serum proteins.
Retentate
Volume
200 pLa
600 pLa
10 mL a
200 pL a

Dialysate
Volume
1400 pL
2400 pL
10 mL
2400 pL

h2o

t3

T4

1
5
5
1.5

6
24
32
12

6
24
32
12

200 pLb

2400 pL

1.5

18

18
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Figure 5.1 Retentate and dialysate volume affects rates of diffusion.
Diffusion of O 3H20, □ 125I-T3 and A125I-T4 when retentate and/or dialysate volumes
differ. Top Left (10 mL : 10 mL), Top Right (200 pL : 1400 pL), Bottom Left (600 pL :
2400 pL), Bottom Right (200 pL : 2400 pL).

86

87

Figure 5.2 Normal serum proteins affect the rate of diffusion.
The diffusions of o 3H20, □ 125I-T3 and A 125I-T4 at 37°C in the absence (left) and
presence (right) of normal serum proteins. (200 pL retentate and 2400 pL dialysate
volumes were used in both.)
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Discussion
3

The application of four equilibrium dialysis methods to H2O,

125

,

I-T3 and

j 25

I-T4

provides previously unreported evidence on the diffusion of thyroid hormones during
dialysis (Figure 1 & 2). Free thyroid hormones do not diffuse through semi-permeable
dialysis membranes at the same rate as water. The presence of serum proteins has no
affect on the diffusion rate of water while having a 50% decrease in the diffusion rate for
both thyroid hormones. These data show the significant role that thyroid hormone
binding serum proteins have on the rate of dialysis of thyroid hormones. Based on the
findings of this study, equilibrium dialysis methods used for the measurement of free T3
or free T4 in aqueous solutions should be characterized for rates of hormone diffusion
related to protein binding affects as well as to retentate and dialysate volumes.
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Introduction
The experiments and data described in this chapter were performed to fulfill the
specific aims of the study and are currently being incorporated into manuscripts for
publication. The results of these experiments provide additional insight into the first two
specific aims of the dissertation: (1) To study dialyzed and ultrafiltered human serum in
analog-based free T4 immunoassays. (2) To determine the contributions of serum proteins
and protein bound T4 to analog-based free T4 determinations.

Materials and Methods
Normal human serum
We obtained normal human serum from 16 healthy male volunteers, ages 21 to 55
years. These sera were pooled. Serum collection was approved by the institutional review
board, and serum samples were given anonymous identifiers. In this pool, serum thyroidstimulating hormone, total T4, free T4, thyroxin-binding globulin, transthyretin, and
albumin were within their respective reference intervals, and test results for anti-T4, antiT3, and anti-IgG antibodies and for salicylates were negative (testing performed at Quest
Diagnostics) (data not presented).

T4 immunoassays
Seven direct analog-based free T4 immunoassays were studied: Bayer Centaur,
Roche Elecsys, TOSOH 600 II, Ortho Vitros, Beckman Access, Abbott AxSym and DPC
Immulite 2000. One direct dialysis free T4 radioimmunoassay (Antech Diagnostics) and
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one direct total T4 immunoassay (Diagnostic Products Corp) were applied to the same
solutions.
Each assay was performed according to its manufacturer’s instructions. Each T4
result reported was a mean of triplicate. We detected and quantified gamma radiation by
use of a Gamma 4000 multiwell automated gamma counter (Beckman-Coulter).

T4-depleted normal human serum
We stripped an aliquot of the serum pool of T4 using Amberlite IRA-410 anion
exchange resin as previously described (Chapter 2). No residual total T4 was detected by
the total T4 radioimmunoassay, and no dialyzable T4 was detected by the nonanalog free
T4 immunoassay.

Sodium levothyroxine
We obtained sodium levothyroxine, for injection, in 500-pg vials (Bedford Labs).
It was dissolved at room temperature in 5 mL of 9 mL/L NaCl, USP grade (Abbott Labs).
This produced a stock solution containing 125 pmol/L (10 000 pg/dL) sodium
levothyroxine.

Equilibrium dialysis
We obtained dialysis devices and dialysate buffer from Antech Diagnostics. The
chemical composition of this buffer has been reported (Chapter 2). Serum samples were
dialyzed for 18 h at 37°C in an Isotemp Incubator, model 630D (Fisher Scientific). A
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moisture-saturated atmosphere was maintained during dialysis by enclosing dialysis cells
in containers with open water reservoirs.

Serum pH control
When dialysis was applied, the pH of serum dialysate and retentate was controlled
to 7.4 (±0.1) during equilibrium dialysis at 37°C by the HEPES acid in dialysate buffer
(Chapter 2). At equilibrium, the final HEPES ion concentration was calculated to be 54
mmol/L.

Free T4 adsorption to container surfaces
Free T4 can adsorb onto solid surfaces from aqueous solutions. We tested the
borosilicate glass vials and test tubes used (Fisher Scientific) for free T4 adsorption as
described in Chapter 2.

Experimental strategies

The previously described analog-based free T4 immunoassays, direct dialysis free
T4 immunoassay and direct non-analog total T4 immunoassay were applied to the
following normal human serum based solutions:
•

The fractions of serum T4 obtained by equilibrium dialysis.

•

Varied concentrations of sodium levothyroxine added to T4 depleted normal
human serum at concentrations ranging from 3 to 24 pg/dL. The dialyzable T4 in
these solutions (direct equilibrium dialysis) was (0.6 to 9.7 ng/dL).
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•

Varied concentrations of sodium levothyroxine added to normal human serum
dialysate at concentrations ranging from 0.05 to 21 jag/dL.

•

Varied concentrations of serum proteins, protein bound T4 and total T4 were
concentrated, while free T4 concentration remained constant. Equilibrium dialysis
was applied to normal serum. One aliquot of retentate was undiluted. Other
aliquots of the normal serum retentate were diluted from 90% to 30% using the
normal serum dialysate as the diluent. Thus, serum proteins, protein bound T4 and
total T4 were varied from a low of 30% of native serum levels to a high of 100%
of native serum levels, while free T4 remained constant. The variation in total T4
concentrations was confirmed by measuring total T4. The constancy of free T4
concentration was confirmed by measuring dialyzable T4 (Figure 6.5).

•

Varied concentrations of serum proteins and protein-bound T4 were progressively
replaced with free T4 while total T4 was held constant. We applied equilibrium
dialysis to normal serum. We measured the total T4 in retentate using the total T4
immunoassay and added sodium levothyroxine solution to the dialysate to match
the concentration of total T4 in the retentate. The retentate was progressively
diluted with T4-enriched dialysate to a dilution of 1 to 4000. We measured
dialyzable T4 by use of nonanalog free T4 immunoassay. High dialyzable T4
concentrations were diluted with immunoassay zero calibrator, as needed, to bring
them into the interval quantified by the nonanalog free T4 immunoassay. These
dialyzable T4 measurements varied from 1.3 to 634 ng/dL (Table 6.2). Total T4
concentrations were constant and unchanged as measured by direct total T4 RIA
(6.0 ug/dL).
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Results

Following equilibrium dialysis, the protein bound fraction of normal serum
yielded test results from all seven free T4 immunoassays (Table 6.1). The free fraction of
normal serum T4 did not account for the test results from any of the seven immunoassays
(Table 6.1).
Co-varied concentrations of free T4, protein bound T4 and total T4 yielded test
results from all assays. The lowest test result, 0.4 ng/dL, was associated with a total T4
concentration of 3000 ng/dL, and a dialyzable T4 concentration of 0.6 ng/dL. The highest
test result, 5.8 ng/dL, was associated with a total T4 concentration of 21,000 ng/dL, and a
dialyzable T4 concentration of >10 ng/dL. These T4 concentrations overlap the
concentrations found in human sera (Figures 6.1 & 6.2).
Varied concentrations of free T4 also yielded test results when serum proteins and
protein bound T4 were not present. The lowest test result, 0.1 ng/dL, was associated with
a free T4 concentration of 250 ng/dL. The highest test result, 11.5 ng/dL, was associated
with a free T4 concentration of 12,000 ng/dL (Figure 6.3). These free T4 concentrations
did not overlap the concentrations of free T4 found in human sera. They exceed the free
T4 concentrations and overlap the concentrations of total T4 found in human sera.
Comparing the responses of these seven analog-based free T4 immunoassays to
T4 in the presence and absence of serum proteins yields striking inconsistencies. While
both sets of solutions applied to the seven assays result in reported mean T4 values of 3.5
ng/dL, they are clearly responding to two very different forms of T4 (Figure 6.4).
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When serum protein concentrations, protein bound T4 concentrations, and total T4
concentrations were varied from 100% to 30% of whole serum concentrations while free
T4 was constant, the seven analog-based free T4 test results varied wildly (Figure 6.5). At
100% of normal serum protein and total T4, the reported free T4 values ranged from 0.9 to
1.3 ng/dL. While at 30% of normal serum protein and total T4 concentrations, the
reported free T4 values ranged from 0.6 to 3.9 ng/dL. Dialyzable free T4 was constant and
unchanged across the same sample range (Figure 6.6).
When free T4 progressively replaced protein bound T4 while total T4 was
constant, most of the analog-based free T4 assays reported measurements that were not
related to free T4 concentrations, total T4 concentrations, protein bound T4 concentrations
or serum protein concentrations (Table 6.2).
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Table 6.1 Normal human serum was applied to equilibrium dialysis. Both fractions
obtained after dialysis were applied to seven analog-based free T4 immunoassays. These
assays did not detect the free T4 in serum dialysate. These assays reported test results for
retentates, the fraction containing serum proteins, protein bound T4 and free T4.
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Table 6.1. The fractions of normal serum T4 that account for test results (ng/dL).
Centaur

Elecsys Tosoh Access Vitros AxSYM Immulite

Dialysate

ND

ND

0.4*

ND

0.3*

ND

ND

Retentate

1.1

1.3

1.0

1.0

1.1

0.9

1.3

* Denotes a false T4 value (see Results)
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Table 6.2 Seven analog-based free T4 immunoassays were applied to solutions where
total T4 was held constant and protein bound T4 was progressively replaced with free T4.
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Table 6.2. Seven analog-based free T4 assays were applied to solutions where total T4 was held constant
while serum protein, protein bound T4 and free T4 were varied by dilution. (ng/dL)

im

Dialvzable
i4

Centaur

Elecsys

Vitros

AxSym

Tosoh

Access

Immulite

86.000

1.3

1.3

1.3

1.1

0.9

1.0

1.0

1.3

21.500

6.9

3.8

3.9

5.7

2.9

> 10

4.2

2.8

8.600

26

6.2

6.1

>7

4.3

> 10

5.4

3.8

2.150

110

8.2

7.5

>7

5.3

> 10

>6

4.4

0.860

306

8.0

7.7

>7

5.3

> 10

>6

4.0

0.215

435

7.3

6.8

>7

5.2

> 10

>6

4.3

0.086

524

6.8

5.9

>7

4.9

> 10

>6

3.8

0.022

634

6.8

5.9

>7

4.8

> 10

>6

3.9

Protein
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Figure 6.1 Comparison of analog-based free T4 measurements in the presence of normal
serum proteins. Analog free T4 test results vs. dialyzable free T4 measurements.
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Figure 6.2 Comparison of analog-based free T4 measurements in the presence of normal
serum proteins. Analog free T4 test results vs. total T4 added to serum (gravimetrically
added).
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Figure 6.3 Comparison of analog-based free T4 measurements in the absence of serum
proteins. Analog free T4 test results vs. free T4 added to serum dialysate (gravimetrically
added).
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Figure 6.4 Comparison of analog-based free T4 measurements, from seven
immunoassays, in the presence of serum proteins and in the absence of serum proteins.
The difference between analog free T4 test results when free T4 concentration changed
from 0.6 to 9.7 ug/dL (normal serum proteins present and constant) to 0.05 to 15 ug/dL
(when serum proteins are absent).
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The Influence of Serum Proteins on Analog-based Free T4 Measurements
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Figure 6.5 Seven analog-based free T4 immunoassays were applied to progressive
dilutions of serum protein and total T4, while free T4 was held constant.
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Figure 6.6 A direct equilibrium dialysis free T4 assay was applied to progressive
dilutions of serum protein and total T4, while free T4 was held constant.
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Discussion
The data published in Chapter 2 and the unpublished data contained in this
chapter present clear and valid experiments that were applied to the characterization of
analog-based free T4 immunoassays. Equilibrium dialysis is a well characterized
procedure that can retain T4 binding serum proteins and protein bound T4 while water and
free T4 move across semi-permeable membranes. Free T4 concentrations should be equal
on both sides of dialysis membranes when equilibrium is reached. Dialyzable T4, at
physiologic concentrations, is measurable by non-analog free T4 immunoassays (Nelson
1988, Wilkinson 1991). Applying serum-based solutions obtained from the two fractions
of serum dialysis to the characterization of analog-based free T4 immunoassays is a new
and novel concept that has yielded striking results.
In the absence of serum proteins, increasing serum total T4 concentrations to 250
ng/dL lead to a concentration of dialyzable T4 that was measured by analog free T4
immunoassays. This is a clinically irrelevant concentration of free T4. It is a clinically
relevant concentration of total T4. Increasing concentrations of T4 in normal serum
dialysate (no proteins present) yielded a range of free T4 concentrations that were
measured by analog free T4 immunoassays. These measurements were 0.1-11.5 ng/dL
(Figure 6.3). The concentrations of T4 added ranged from 0.05 to 12.0 pg/dL (50 to
12,000 ng/dL). These are clinically irrelevant free T4 concentrations. They are clinically
relevant concentrations of total T4, overlapping both the hypothyroid and euthyroid
ranges. These data provide direct evidence that analog-based free T4 immunoassays
respond to and measure clinically relevant total T4 concentrations.
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In the presence of clinically relevant serum protein concentrations, analog-based
free T4 measurements were obtained with clinically relevant total T4 concentrations (3 to
21 pg/dL). The corresponding dialyzable T4 concentrations were 0.6 to 7.5 ng/dL. These
are concentrations not detected by analog free T4 assays (Figure 6.3). The data contained
in Figures 6.2 and 6.3 document striking evidence of insensitivity and nonspecificity
among analog-based free T4 immunoassays. It is important to note that analog-based free
T4 measurements correlated closely with dialyzable T4 measurements (Figure 6.1),
despite the evidence of insensitivity and nonspecificty. This can be attributed to the close
correlation between serum total T4 concentrations and free (dialyzable) T4 concentrations,
in the presence of normal serum proteins.
Further experiments characterizing the lack of specificity among these assays
were used to determine if these analog-based assays would track normal and constant free
T4 concentrations while serum proteins and total T4 were progressively diluted. Under
these conditions, analog free T4 estimates did not correlate with dialyzable free T4
concentrations (Figures 6.5 and 6.6).
A final experiment was introduced to determine if these analog-based assays
would track total T4 concentrations while protein bound T4 was progressively replaced
with free T4. The results again confirmed a lack of specificity and sensitivity for free T4
(Table 6.2).
These new data are inconsistent with a widely accepted concept of analog-based
free T4 immunoassays (Christofides 1992, Midgley 1993, Midgley 2001). These assays
are based on the displacement of a conjugated form of T4 (analog) from T4 antibodies by
the T4 in serum. The current concept assumes that analog-based free T4 measurements
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will be obtained with free T4 concentrations and the free form of T4 only. That
assumption is inconsistent with the experimental data presented in Chapter 2 and this
chapter (Figures 6.2, 6.3, 6.5, 6.6 and Tables 1 & 2).
There are two simple hypotheses that could explain the present data. One
postulates that serum protein T4 complexes, as well as free T4, are capable of displacing
T4 analogs from T4 antibodies. This hypothesis is attractive because it is simple and
untested.
Another simple hypothesis is that T4 binding inhibitors are present, releasing
protein bound T4 from serum protein T4 complexes and raising free T4 concentrations
during the assay procedure. Suppliers of assay reagents could easily refute or confirm this
hypothesis by fully disclosing the compounds in their reagent solutions.
Previous studies have found correlations between analog free T4 measurements
and dialyzable T4 concentrations and are confirmed by our data (Figure 6.1). Unlike
earlier studies, our experiments also looked for correlations between analog free T4
measurements and total T4 concentrations. Correlations were found (Figures 2.1, 2.2 and
Table 6.2). This leads to the question of which is the direct correlation and which is the
indirect correlation. The data presented in Chapter 2 and this chapter led us to conclude
that the direct correlation is with total T4 concentrations.
A question to be answered is whether the insensitivity and nonspecificity found in
these analog free T4 immunoassays will be present in other, as yet untested, analog-based
free T4 immunoassays. It is time for project directors and journal editors to question the
sensitivity and specificity of direct free T4 immunoassays. They have been used for
decades, without fully understanding their characteristics.
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Conclusions
The progressive development of the following focused and previously
unanswered questions led to the specific experiments described in this dissertation: (1)
Are direct free T4 determinations sometimes attributable to serum compounds other than
thyroid hormones (i.e., “blank effects”)? (2) What portion of serum T4 is most closely
related to direct free T4 determinations, following equilibrium dialysis and ultrafiltration?
(3) What concentrations of T4 are most closely related to direct free T4 determinations,
when T4 binding serum proteins and protein bound T4 are not present? (4) What
concentrations of T4 are most closely related to direct free T4 determinations, when T4
binding serum proteins are held constant? (5) What T4 is most closely related to direct
free T4 determinations, when free T4 is held constant, while T4 binding serum proteins,
protein bound T4 and total T4 are varied? (6) What T4 is most closely related to direct free
T4 determinations, when free T4 replaces protein bound T4 while total T4 concentration is
held constant? (7) How do analog-based free T4 determinations relate to those obtained
by direct equilibrium dialysis free T4 assays and total T4 assays?
The data presented in Chapters 3-5 illustrate the technical deficiencies of
ultrafiltration as a method for separating free T4 from serum proteins; that it is unreliable
and should not be used in free hormone assays. Equilibrium dialysis, on the other hand, is
shown to be a well characterized and reliable method. More importantly, the evidence
presented in this dissertation (Ch. 2 & 6) supports our hypothesis: Direct free thyroxine
immunoassays do not detect and quantify free T4 but detect and quantify protein bound
thyroxine and/or total thyroxine. These assays are insensitive and nonspecific for free T4.
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